Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 16th October 2024
Solactive Global Health Services & Technology Americas:
In the ordinary adjustment, the following composition will be implemented effective open 16th October 2024:
ABBOTT LABORATORIES |
ABBVIE INC |
ADDUS HOMECARE CORP |
AGILENT TECHNOLOGIES INC |
AMEDISYS INC |
AMGEN INC |
AXONICS INC |
BECTON DICKINSON AND CO |
BIOGEN INC |
BOSTON SCIENTIFIC CORP |
CATALENT INC |
CHEMED CORP |
THE CIGNA GROUP |
COOPER COMPANIES INC |
DANAHER CORP |
DAVITA INC |
ELEVANCE HEALTH INC |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
GE HEALTHCARE TECHNOLOGIES INC |
GILEAD SCIENCES INC |
GLAUKOS CORP |
HCA HEALTHCARE INC |
HOLOGIC INC |
IDEXX LABORATORIES INC |
INCYTE CORP |
INNOVIVA INC |
INTUITIVE SURGICAL INC |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERIT MEDICAL SYSTEMS INC |
PFIZER INC |
PREMIER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
REGENERON PHARMACEUTICALS |
ROIVANT SCIENCES LTD |
ROYALTY PHARMA PLC- CL A |
STERIS PLC |
STRYKER CORP |
TELEFLEX INC |
THERMO FISHER SCIENTIFIC INC |
U.S. PHYSICAL THERAPY INC |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
VIATRIS INC |
WATERS CORP |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |
FLEURY SA |